Economic Performance - In the first five months of 2025, the cumulative year-on-year export growth was 6.0%, with a cumulative trade surplus of $471.9 billion, the highest for the same period in history[43] - The contribution of net exports to GDP in Q1 was 2.13%, accounting for 39.5% of GDP growth[43] Industrial Production - Industrial production maintained stability with an average year-on-year growth of 6.4% from January to May, surpassing the previous year's average of 5.6%[54] - The equipment manufacturing sector showed significant growth, supported by both investment in equipment updates and exports[54] Investment Trends - Fixed asset investment growth was 3.7% year-on-year in the first five months, with manufacturing and infrastructure investments remaining stable, while real estate investment continued to be a drag[21] - Equipment updates contributed over 60% to overall fixed asset investment growth, with a year-on-year increase of 17.3% in equipment purchases from January to May[25] Consumer Behavior - The contribution rate of the "old-for-new" consumption policy to overall retail sales growth was 24.3% cumulatively from January to May, with May's contribution reaching 31.8%[13] - Consumer spending inclination was at 63.1% in Q1 2025, still below pre-pandemic levels, indicating ongoing challenges in boosting consumer confidence[18] Real Estate Market - Real estate investment is expected to maintain a decline of around -10% in the second half of 2025, with pressures on sales and investment continuing[42] - The land transaction area in 100 cities saw a year-on-year decrease of 9.7% in the first five months, indicating ongoing challenges in the real estate sector[34] Policy Impact - The government has implemented a series of financial policies to stabilize the market, including a 0.5% reduction in the reserve requirement ratio and various structural tools aimed at boosting consumption and supporting small and medium enterprises[75] - The issuance of special bonds for land reserves and urban renewal projects has increased, with a focus on supporting real estate-related investments[81]

Group 1 - The report highlights the frequent release of new products by companies like Xiaomi and Honor, emphasizing the importance of the domestic production process for new materials [5][6] - The Chinese government is supporting equipment upgrades in the petrochemical and chemical industries with a funding of 200 billion yuan, which is expected to accelerate the modernization of these sectors [5][6] - The introduction of new products, such as Xiaomi's first SUV and Honor's latest smartphones, is seen as a significant advancement in China's consumer electronics sector, potentially driving the domestic supply chain and high-end material development [6][9] Group 2 - The report indicates that the securities sector may experience upward momentum after a period of consolidation, with technical indicators showing positive trends [11][12] - The Shanghai Composite Index has shown resilience, maintaining above key moving averages despite recent fluctuations, suggesting potential for further gains [19][20] - The report notes that large capital inflows into the market indicate strong buying interest, which may support continued upward movement in the securities sector [15][19] Group 3 - The report tracks industry performance, noting that the petrochemical index has underperformed compared to the broader market, while the basic chemical index has outperformed [7][22] - Specific sub-sectors such as membrane materials and other plastic products have shown significant price increases, indicating strong demand and potential investment opportunities [7][22] - The report emphasizes the importance of selecting resilient and advantageous sectors within the chemical industry, particularly those benefiting from supply-side reforms and domestic production initiatives [9][10]

Investment Rating - The investment rating for the company is "Buy" (maintained) [6][7]. Core Insights - The report highlights the resumption of U.S. ethane exports to China, which is expected to benefit the company significantly due to its core assets in U.S. ethane exports [6]. - The company has a competitive edge with its low ethylene production costs and integrated supply chain advantages, positioning it well for future growth [6]. - The report projects substantial revenue and profit growth for the company from 2025 to 2027, with expected revenues of 588.39 billion, 681.97 billion, and 788.11 billion respectively, and net profits of 72.21 billion, 92.46 billion, and 117.78 billion respectively [7][8]. Summary by Sections Company Overview - The company has a total share capital of 336,865 million shares and a closing price of 17.31 as of July 2, 2025 [1]. - The asset-liability ratio stands at 53.62%, with a price-to-book ratio of 1.83 and a weighted return on equity of 5.05% [1]. Market Dynamics - The U.S. has lifted the export ban on ethane to China, which is crucial for the company's operations as it owns a significant export terminal in the U.S. [6]. - The report notes that the construction of new ethane terminals in the U.S. is unlikely due to high investment costs and regulatory challenges [6]. Competitive Position - The company is positioned in the lowest cost range for ethylene production in China, benefiting from technological advancements and lower raw material costs [6]. - The company plans to expand its fleet of VLEC ships to enhance its logistics capabilities, with an investment of 257 billion for six new vessels [6]. Financial Projections - Revenue growth rates are projected at 28.90% for 2025, followed by 15.90% and 15.56% for 2026 and 2027 respectively [8]. - The expected earnings per share (EPS) are projected to be 2.14, 2.74, and 3.50 for the years 2025, 2026, and 2027 respectively [7][8].

Investment Rating - The report maintains a positive outlook on the semiconductor industry, highlighting structural opportunities in AI computing, AIOT, semiconductor equipment, and key components [4]. Core Insights - The semiconductor industry showed signs of recovery in June 2025, with increasing prices and improving demand across various segments, including smartphones, tablets, TWS headphones, wearable devices, smart home products, AI servers, and new energy vehicles [4][5]. - The report indicates that the overall semiconductor demand is expected to continue its recovery into July, despite high inventory levels and relatively abundant supply in the short term [4]. - The report emphasizes the importance of AI innovations, with new consumer electronics products being launched, such as AI glasses from Xiaomi and Meta, which are expected to drive demand in the sector [4][5]. Monthly Market Review - The semiconductor sector experienced a 5.96% increase in June, outperforming the broader market, which saw a 2.50% rise in the CSI 300 index [11][13]. - The semiconductor industry's valuation metrics, including PE and PB ratios, are currently at high historical percentiles, indicating a strong market sentiment towards the sector [21][22]. Semiconductor Supply and Demand Data - Global semiconductor sales in April 2025 showed a year-on-year increase of 22.68%, with a cumulative growth of 18.93% from January to April 2025, reflecting a robust recovery in demand [4]. - The report notes significant price increases in memory chips, particularly DDR4, driven by supply constraints and increased market demand [4]. Downstream Demand Tracking and Forecast - The report highlights that downstream demand for semiconductors is strong in TWS headphones, wearable devices, AI servers, and new energy vehicles, with notable growth rates in these segments [4][5]. - Global smartphone shipments in Q1 2025 increased by 1.53%, while new energy vehicle sales saw a year-on-year growth of 19.08% in April 2025 [4]. Industry News Highlights - The report mentions significant developments in AI infrastructure, including Nvidia's plans to build AI factories in Europe and the release of new AI products by major tech companies [5]. - The report suggests that the semiconductor industry is likely to benefit from ongoing AI innovations and the expansion of the ASIC market, with projections for the market size to increase from $75 billion to $94 billion by 2028 [5]. Investment Recommendations - The report advises investors to consider leading companies in the AIOT sector, such as Lexin Technology and Hanguang Technology, as well as those involved in AI-driven innovations and domestic supply chain replacements [5].

Core Viewpoints - The securities sector is currently facing multiple resistance levels near previous highs and trading dense areas, which may lead to short-term consolidation. However, the short-term moving averages are trending upwards, and the MACD indicators across daily, weekly, and monthly charts show a positive cross, indicating no significant signs of weakness in technical conditions. There is active large-scale buying at lower levels, suggesting potential for upward movement after sufficient consolidation [3][4][6]. Summary by Sections Technical Analysis of the Securities Sector - The report reviews a previous analysis from May 16, 2025, which indicated that the securities index was in a recovery phase with limited downside potential. The index had a maximum increase of over 12% following the analysis, supported by strong buying at lower levels [3][6]. - Currently, the index is encountering resistance near the high formed on March 14, 2025. Despite this, it has shown resilience by bouncing off the 20-day moving average, forming a bullish "Red Three Soldiers" candlestick pattern, and reaching the previous high pressure level [3][6]. - The technical indicators are improving, with multiple moving averages aligned positively, indicating active buying momentum. The MACD indicators are also showing a positive cross, further supporting the bullish outlook [3][9]. Market Dynamics - Large-scale funds have been actively entering the market, with net inflows exceeding 30 billion yuan during the consolidation phase. Notably, there were nine days with net inflows over 800 million yuan, indicating strong buying interest despite the presence of multiple resistance levels [3][10]. - The report emphasizes that while the index is under pressure, the active large-scale funds suggest that there is still potential for upward movement after sufficient consolidation [3][10].

Group 1 - The report highlights a resilient actual GDP growth forecast of over 5% for Q2 2025, despite nominal GDP pressures due to declining economic data, particularly in real estate investment [6][7] - The report emphasizes the importance of domestic demand and technology as key investment themes, especially in light of the upcoming political bureau meeting that will outline economic policies for the second half of the year [7][8] - The agricultural sector, particularly pig farming, is expected to see a price increase due to reduced supply pressure and improved profitability, with specific companies like Muyuan Foods and Wens Foodstuffs recommended for investment [8][9][10] Group 2 - The pharmaceutical and biotechnology sector is gradually stabilizing, with a reported revenue of CNY 795.03 billion in the first four months of 2025, a year-on-year decline of 2.1% [12][13] - The report notes a significant increase in the number of innovative drug projects and collaborations, with 51 innovative drug projects worth over USD 48 billion completed in the first five months of 2025 [13][14] - Investment recommendations include focusing on innovative drug companies with differentiated products and strong potential for international expansion, such as Kelun Pharmaceutical and Betta Pharmaceuticals [14][27] Group 3 - The basic chemical sector is experiencing a recovery, with the SW basic chemical index outperforming the market, driven by a decrease in raw material costs and potential supply-side reforms [16][17] - Companies with strong cost advantages and those involved in supply-side reforms, such as Hoshine Silicon Industry and Zhejiang Longsheng, are highlighted as potential investment opportunities [18][19] - The report also points to new consumer trends driving demand for health additives and domestic substitutes in the chemical materials sector, with companies like Jinfa Technology and Shengquan Group recommended for investment [19] Group 4 - The electronics sector is witnessing a recovery, with Xiaomi's launch of its first AI glasses and other innovative products expected to strengthen its market position [20][21] - The report indicates a 4.61% increase in the electronic index, outperforming the broader market, with specific focus on AI-driven sectors and semiconductor equipment as key investment areas [22][23] - Recommended companies include companies benefiting from strong domestic and international demand in the AIOT field, such as Espressif Systems and Rockchip Electronics [23] Group 5 - The GLP-1 drug market is gaining attention with the approval of the first dual-target weight loss drug in China, which is expected to drive further interest in the sector [24][26] - The report notes that the pharmaceutical sector's overall performance has been mixed, with a 1.60% increase in the biopharmaceutical index, but specific segments like medical services and devices are performing well [25][27] - Investment suggestions include focusing on companies involved in innovative drug development and medical devices, such as Betta Pharmaceuticals and Yao Ming Pharmaceutical [27][28]

- The report discusses the structural optimization of the supply side in the chemical industry, emphasizing the potential for supply compression in sectors like silicone, membrane materials, chlor-alkali, and dyes, with representative companies such as Hesheng Silicon Industry and Zhejiang Longsheng highlighted[178][178][178] - It identifies the demand-driven alpha opportunities in the chemical industry, focusing on health additives and sugar substitutes, driven by new consumption trends and regulatory support, with key players like Bailong Chuangyuan and Jinhe Industrial noted for their differentiation capabilities[178][178][178] - The report highlights the acceleration of domestic substitution in China's chemical new materials sector, with a self-sufficiency rate of approximately 56%, and identifies opportunities in high-end engineering plastics, semiconductor materials like photoresists, and thermal interface materials, with companies such as Kingfa Sci & Tech, Shengquan Group, and Tongcheng New Materials as key beneficiaries[178][178][178]

[Table_Reportdate] 2025年06月30日 [table_invest] 标配 行 业 周 报 [Table_Authors] 证券分析师 方霁 S0630523060001 fangji@longone.com.cn 联系人 董经纬 djwei@longone.com.cn [table_stockTrend] [table_product] 相关研究 1.博通2025Q2 AI营收大幅增 长，存储市场持续回暖——电 子行业周报2025/6/2-2025/6/8 1. DDR4价格大涨，Marvell释放 ASIC市场乐观预期——电子行业周 报（2025/6/16-2025/6/22） 2. 英伟达拟在欧洲新建多座AI工 厂，华为发布Pura 80系列——电子 行业周报（2025/6/9-2025/6/15） 3. 博通2025Q2 AI营收大幅增长， 存储市场持续回暖——电子行业周 报（2025/6/2-2025/6/8） [Table_NewTitle] 小米发布首款AI眼镜，端侧AI创新热潮 持续 ——电子行业周报2025/6/23-2025/6/29 [table_main] 投资 ...

[Table_Reportdate] 2025年06月30日 超配 [证券分析师 Table_Authors] 杜永宏 S0630522040001 dyh@longone.com.cn 证券分析师 上周（06月23日-06月27日）医药生物板块整体上涨1.60%，在申万31个行业中排第 24位，跑输沪深300指数0.35个百分点。当前医药生物板块PE估值为27.67倍，处于历史 中低位水平，相对于沪深300的估值溢价为124%。子板块涨幅前三的为医疗服务(申万)、 医疗器械(申万)、医药商业(申万)、涨幅分别为2.92%、2.10%、2.08%。个股方面，上周 上涨的个股为397只（占比83.76%），下跌的个股70只（占比14.77%）。涨幅前五的个股分 别为神州细胞（30.45%）、浩欧博（27.08%）、华人健康（25.97%）、华强科技（22.94%）、 迈威生物-U（17.44%）。 ➢ 行业要闻： 2025年6月27日，信达生物发布公告，宣布信尔美®（玛仕度肽注射液）获NMPA批准 上市，用于成人肥胖或超重患者的长期体重控制。信尔美®（玛仕度肽注射液）是本公司 与礼来制药共同推进的一款胰高血糖素 ...

0 5 10 15 20 25 30 35 40 2021-01 2022-01 2023-01 2024-01 2025-01 生猪均价（元/公斤） 图：生猪均价 资料来源：钢联数据，东海证券研究所 0 100 200 300 400 500 600 700 2022-01 2022-03 2022-05 2022-07 2022-09 2022-11 2023-01 2023-03 2023-05 2023-07 2023-09 2023-11 2024-01 2024-03 2024-05 2024-07 2024-09 2024-11 2025-01 2025-03 2025-05 7KG仔猪价格（元/公斤） 资料来源：钢联数据，东海证券研究所 图：仔猪均价 ● 今年以来生猪价格平稳震荡，仔猪价格先涨后跌。根据钢联数据，6月27日生猪均价14.56元/公斤，年初以来下降7.6%，同比 上升0.9%。春节后至端午节前，生猪价格维持在14-15元/公斤左右震荡，淡季不淡，强于市场预期。主要由于冻品库存下降、 二次育肥增加以及消费需求恢复，支撑猪价。6月以后受集中出栏以及需求季节性偏弱影响，猪价跌破14元/ ...